New York, NY (PRWEB) June 13, 2014
Kyowa Hakko U.S.A., Inc. (Kyowa Hakko USA), the wholly owned subsidiary of KYOWA HAKKO BIO CO., LTD. (Kyowa Hakko Bio), has announced that Setria® Glutathione meets the U.S. Pharmacopeial Convention (USP) monograph for glutathione.
“Recently, the USP dietary supplements compendium released the first monograph for glutathione. We were happy to see this standardization and we are happy to announce that Setria glutathione meets the new compendia,” said Dr Danielle Citrolo, PharmD, registered pharmacist and technical services manager for Kyowa Hakko USA.
By meeting the monograph, we are assisting our manufacturers in their qualification process by establishing standards of ingredient identity, strength, quality, and purity. These standards help limit the introduction of potential adulterants and contaminants, and serve as a quality benchmark in the purchasing of ingredients in the global marketplace.
A USP monograph includes the name of the ingredient or preparation; the definition; packaging, storage, and labeling requirements; and the specification. The specification consists of a series of tests, procedures for the tests, and acceptance criteria. These tests and procedures require the use of official USP Reference Standards.
About Setria Glutathione
Setria® glutathione, manufactured by Kyowa Hakko Bio, is a clinically studied form of glutathione that, when taken orally1, has been shown to replenish the body's reserves, which may be depleted as a result of poor lifestyle choices, stress or natural aging. Called the "master antioxidant," glutathione helps protect cells in the body from the damaging effects of oxidative stress and toxins*. Setria glutathione is manufactured through a patented fermentation and patent pending for increasing natural killer (NK) cell activity*, is pure, vegetarian and allergen-free. For more information about Setria glutathione, visit http://www.setriaglutathione.com.
1 Richie JP Jr, Nichenametla S, Neidig W, Calcagnotto A, Haley JS, Schell TD, Muscat JE. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2014 May 5. [Epub ahead of print], DOI 10.1007/s00394-014-0706-z
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
About Kyowa Hakko USA
Kyowa Hakko USA is the North American sales office for Kyowa Hakko Bio, an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. Kyowa Hakko Bio is the maker of branded ingredients including Cognizin® Citicoline, Pantesin® Pantethine, Setria® Glutathione, Sustamine® L-Alanyl-L-Glutamine as well as the topical ingredient Lumistor® Hydroxyproline. For more information, visit http://www.kyowa-usa.com.
The U.S. Pharmacopeial Convention (USP) is a scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements manufactured, distributed and consumed worldwide. USP’s drug standards are enforceable in the United States by the Food and Drug Administration, and these standards are used in more than 140 countries.
USP standards are developed and revised by more than 900 volunteer experts, including international participants, who work with USP under strict conflict-of-interest rules. Since its founding in 1820, USP has helped secure the quality of the American drug supply. Building on that legacy, USP today works with scientists, practitioners, and regulators of many nations to help protect public health worldwide.
# # #